CD BioSciences is a growing life science company focusing on 3D bioprinting fields such as bio-ink design, 3D printing technology platform development and in vitro research micro-models customization. Here, our experienced experts can provide you with a series of 3d printing bioinks and solutions based on 3Dmicroflu™ technology platform for you to choose from according to your project needs. In the process of drug development, no matter what type of drug, models are needed for the initial drug screening. CD BioSciences can help you achieve high throughput in drug screening by replacing inaccurate 2D cell and animal models. Do you consider choosing 3Dmicroflu™ technology platform to advance your in vitro drug screening process? The following shows the application of 3Dmicroflu™ technology platform in advancing the cellular drug development process.
Cellular drugs are different cell-based agents used in the treatment of diseases and are a clinically effective treatment after radiotherapy and chemotherapy, allowing the implementation of personalized therapy. There are many types of cellular drugs, which can be classified according to their biological properties into traditional somatic cells, immune cells, and different kinds of stem cells. Cellular drugs are currently used in a number of refractory diseases, including hematologic, cardiovascular, gastrointestinal, neurologic, immunologic, and anti-aging diseases. Cell therapy involves many types of cells, and different cellular drugs have their own characteristics. We can choose different cellular drugs to repair diseased cells in order to rebuild damaged functional cells and tissues and restore their biological functions. The emergence of cellular drugs has provided a new way of thinking for the prevention and treatment of cell loss or damaging diseases.
In the face of diseases with high mortality rates, such as cancer, cellular drugs will be the most personalized and precise treatment approach. Currently, cellular drugs have received a lot of attention from researchers as an emerging hot area. Screening models are important in determining the progress of cellular drug development. Here, at CD BioSciences, our proprietary 3Dmicroflu™ 3D bioprinting technology platform can provide you with customizable screening model services which match your project needs.
Cellular drugs have an important role in repairing cancerous cells, damaged cells and cells with slow metabolism, so as the advantages of cellular drugs become more and more apparent, research related to cellular drugs is gaining attention. Cellular drugs have an important role in the repair of cancerous cells, damaged cells and slow metabolizing cells, so as the advantages of cellular drugs become more and more evident, research related to cellular drugs is receiving more and more attention. CD BioSciences has been working on providing customized screening models based on 3Dmicroflu™ technology platform for screening in the development of various drugs, such as cancer, cardiovascular diseases, skin diseases, etc. Our technology platform is based on microfluidic systems and the main advantage is the high resolution 3D printing of single cells. The diagram below shows the general process of 3Dmicroflu™ technology platform involved in cellular drug screening.
Fig. 1. 3Dmicroflu™ technology platform is involved in the construction of disease models for the rapid screening process of cellular drugs.
3Dmicroflu™ technology platform can be involved in the following processes in the engineering of cellular drug development, including cell printing and disease micro-model printing.
The types of cellular drugs are divided into somatic cells, immune cells and stem cells. The flexibility and scalability of 3Dmicroflu™ technology platform allows for the printing of any type of cells, which can facilitate the pre-design work of your cellular drug. Combining the microfluidic system in 3Dmicroflu™ technology platform allows the entire process to be high-resolution single-cell printing.
For particularly difficult-to-cure diseases such as cancer and autoimmune diseases, this is exactly where cellular drugs work best. The emergence of cellular drugs has advanced the process of personalized precision therapy. 3Dmicroflu™ technology platform is a perfect match to facilitate the construction of your complex and customized disease models. Then, high-throughput screening of cellular drugs can be achieved with these disease models that truly reflect the physiological state of the body.
If you have a need for 3Dmicroflu™ technology platform for high-throughput screening of cellular drugs in your drug development program, please feel free to contact us for the selection of cell types and the customization of disease micro-models. We always hope that 3Dmicroflu™ technology platform will provide great assistance and guidance to your drug development process.